CABLE MANUFACTURER H I G H F L A M E R E T A R D A N T S H E A T H F O R R I S E R C A B L E S • Fire performance: CPR classification Dca s1 a1 d0 at a thickness of 350µm • Low shrinkage • Water, UV and chemical resistance • Low CoF • Reduced cable weight by decreasing the jacket thickness from 550µm to 350µm • Provided required CPR classification at a reduced thickness allowing installation in homes and buildings in between walls and floors • Increased cable lifetime due to improved chemical and UV resistance • Enabled fast cable processing ECCOH™ 5702 SEPAP Formulation KEY REQUIREMENTS WHY AVIENT?

PTFE Wire insulation ELECTRICAL EQUIPMENT MANUFACTURER H I G H - T E M P E R A T U R E C A B L E S - O I L & G A S I N D U S T R Y • Formulations suitable for a wide range of cable types, including high-voltage and self-regulating heating applications • Fine-tuned and consistent resistivity • Consistent performance across a wide range of temperatures • Optimized dispersion for ease of processing • Provided tailored solutions for specific conductivity requirements, protecting cables against damage from electrostatic discharge (ESD), arc failures, and temperature fluctuation • Supplied ESD and conductive fluoropolymer solutions in PFA, FEP, ETFE and PVDF • Shared more than 40 years of experience in the processing and formulation of fluoropolymers • Offered a global manufacturing footprint Colorant Chromatics Conductive Formulations KEY REQUIREMENTS WHY AVIENT?

CABLE MANUFACTURER F L A M E - R E T A R D A N T S H E A T H F O R R I S E R C A B L E S • Fire performance: CPR classification Dca s1 a1 d0 at a thickness of 350µm • Low shrinkage • Water, UV, and chemical resistance • Low coefficient of friction (CoF) • Reduced overall cable weight cable by reducing the jacket thickness from 550µm to 350µm • Increased the lifetime value of the cable by providing superior chemical and UV resistance • Provided low CoF on the inner layer, making the solution suitable for use with micro ducts as it’s easier to blow cables inside ECCOH LSFOH 5702 SEPAP Formulation KEY REQUIREMENTS WHY AVIENT?

GLS TPE - Bayer Cap - Spanish BAYER® T A P A S O B R E - M O L D E A D A C O N E L A S T Ó M E R O T E R M O P L Á S T I C O ( T P E ) • Fácil de sujetar y abrir • Requerimientos de diseño: • Logotipo en relieve • Color específico de la marca • Optimiza el espacio en los estantes y reduce el embalaje • Funcionalidad de embalaje mejorada, tanto para el usuario (diseño ergonómico) como en el estante (mejor apilamiento y menos embalaje) • Se ofreció una formulación de valor agregado que permitió al cliente ampliar la diferenciación de la marca en el mercado Elastómero termoplástico GLS™ REQUERIMIENTOS CLAVE ¿POR QUÉ AVIENT?

LTD. (199006136Z) (ACRA) Number Of Shares Currency COMPANY HAS THE FOLLOWING ORDINARY SHARES HELD AS TREASURY SHARES Registered Office Address 3 INTERNATIONAL BUSINESS PARK #04-14/15 NORDIC EUROPEAN CENTRE SINGAPORE (609927) : Date of Address 16/08/2020: Date of Last AGM : 29/08/2020 Date of Last AR : 26/10/2020 FYE As At Date of Last AR : 31/12/2019 Audit Firms NAME ERNST & YOUNG LLP Amount Secured Chargee(s) Charges CurrencyCharge No. Date Registered Source of Address ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Address Date of Appointment XU TAO EB6238077 CHINESE 30/06/2021ACRA DirectorROOM 102, BUILDING 20, SUB LANE 7, LANE 888, LUOJIN ROAD SHANGHAI, 201104, CHINA CHAN BAI RONG S8534833G SINGAPORE CITIZEN 30/06/2021ACRA Director10A BENDEMEER ROAD #26-103 BENDEMEER LIGHT SINGAPORE (331010) LEE SAY ENG A52290094 MALAYSIAN 30/06/2021ACRA Page 2 of 4 Authentication No. : E21642955A Date: 02/08/2021 ACCOUNTING AND CORPORATE REGULATORY AUTHORITY WHILST EVERY ENDEAVOR IS MADE TO ENSURE THAT INFORMATION PROVIDED IS UPDATED AND CORRECT. LTD. (199006136Z) (ACRA) Source of Address ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Address Date of Appointment Director168 JINAN ROAD, BUILDING 10, ROOM 802, SHANGHAI CHINA 200021 CHAN LAI YIN S7480587F MALAYSIAN 28/06/2010ACRA Secretary26 SIMEI STREET 1 #11-08 MELVILLE PARK SINGAPORE (529947) LEE WEI HSIUNG S7927166G SINGAPORE CITIZEN 01/12/2009ACRA Secretary633 JURONG WEST STREET 65 #10-310 SINGAPORE (640633) Shareholder(s) Name Address ID Nationality/Citizenship Place of incorporation/ Origin/Registration Source of Address Address Changed AVIENT CORPORATION T05UF0103G UNITED STATES OF AMERICA ACRA1 33587 WALKER ROAD, AVON LAKE, OHIO 44012, UNITED STATES OF AMERICA Ordinary(Number) Currency 694600 SINGAPORE, DOLLARS Ordinary(Number) Currency 7200000 UNITED STATES OF AMERICA, DOLLARS Page 3 of 4 Authentication No. : E21642955A Date: 02/08/2021 ACCOUNTING AND CORPORATE REGULATORY AUTHORITY WHILST EVERY ENDEAVOR IS MADE TO ENSURE THAT INFORMATION PROVIDED IS UPDATED AND CORRECT.

Microsoft PowerPoint - AVNT Nov 2022 Earnings Presentation AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) D E C E M B E R 2 0 2 2 AVIENT: WHO WE ARE 40 23 9 36 • U.S. and Canada • Latin America • Europe, Middle East & Africa • Asia 25,000+ CUSTOMERS Headquartered in Avon Lake, OH (Cleveland) 9,300+ employees 100+ manufacturing plants Key Financial Data $3.6 billion2022PF Sales $585 million2022PF EBITDA $2.952022PF EPS 100% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 2 Guidance as of November 2, 2022 Webcast WHO WE ARE – VISION, STRATEGY, CULTURE 3 Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Purchase price multiple rapidly declining on strength of business and synergy capture 12 $133 $201 2019PF 2022E 12 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies (1) (1) 11.9% 16.3% 2019PF 2022E EBITDA Margins (1) CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION ($ in millions) (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 13 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 14 Commercial Resources Operating Income ($ in millions) Operating Margins 259 363 At Acquisition 2022E $40 $139 At Acquisition 2022E 9% 22% At Acquisition 2022E Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 7% 46% 67% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 15 Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro Forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 16 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 17 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 18 Adj. Sales EBITDA Specialty Engineered Materials Color Additives and Inks $585M$3,635M (1) Transportation 9% Healthcare 8% 29 C O L O R , A D D I T I V E S & I N K S 2022 REVENUE | $2 .3 B ILL ION US & Canada 35% EMEA 40% Asia 20% Latin America 5% END MARKET REGION 30 Packaging 33% Consumer 22% Healthcare 9% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 1% Figures represent 2022 full year estimates S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2022 PRO FORMA REVENUE | $1 .3 B ILL ION END MARKET US & Canada 50% EMEA 35% Asia 15% REGION 31 Figures represent 2022 full year estimates Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 31% Consumer 28% Healthcare 8% Industrial 13% Building & Construction 5% Telecommunications 3% Energy 2% Defense 1% Asia (20% of sales) Transportation 9% 2022 PROFORMA AVIENT REGIONAL SALES BY END MARKET Packaging 29% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 11% Energy 5% Defense 7% EMEA (35% of sales) Transportation 10% Packaging 14% Consumer 23% Healthcare 11% Industrial 15% Building & Construction 12% Energy 5% Defense 7% US & Canada (40% of sales) Transportation 7% Packaging 49% Consumer 22% Healthcare 8% Industrial 9% Building & Construction 6% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3%Telecommunications 6% Figures represent 2022 full year estimates32

Microsoft PowerPoint - AVNT Nov 2022 Earnings Presentation AVIENT CORPORATION I N V E S T O R P R E S E N T A T I O N (NYSE: AVNT) D E C E M B E R 2 0 2 2 AVIENT: WHO WE ARE 40 23 9 36 • U.S. and Canada • Latin America • Europe, Middle East & Africa • Asia 25,000+ CUSTOMERS Headquartered in Avon Lake, OH (Cleveland) 9,300+ employees 100+ manufacturing plants Key Financial Data 2022PF Sales $3.6 billion 2022PF EBITDA $585 million 2022PF EPS $2.95 100% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 2 Guidance as of November 2, 2022 Webcast WHO WE ARE – VISION, STRATEGY, CULTURE 3 Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world. Purchase price multiple rapidly declining on strength of business and synergy capture 12 $133 $201 2019PF 2022E 12 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies (1) (1) 11.9% 16.3% 2019PF 2022E EBITDA Margins (1) CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION ($ in millions) (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 13 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 14 Commercial Resources Operating Income ($ in millions) Operating Margins 259 363 At Acquisition 2022E $40 $139 At Acquisition 2022E 9% 22% At Acquisition 2022E Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 7% 46% 67% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 15 Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro Forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 16 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 17 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 18 Adj. Sales EBITDA Specialty Engineered Materials Color Additives and Inks $585M$3,635M (1) Transportation 9% Healthcare 8% 29 C O L O R , A D D I T I V E S & I N K S 2022 REVENUE | $2 .3 B ILL ION US & Canada 35% EMEA 40% Asia 20% Latin America 5% END MARKET REGION 30 Packaging 33% Consumer 22% Healthcare 9% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 1% Figures represent 2022 full year estimates S P E C I A LT Y E N G I N E E R E D M AT E R I A L S 2022 PRO FORMA REVENUE | $1 .3 B ILL ION END MARKET US & Canada 50% EMEA 35% Asia 15% REGION 31 Figures represent 2022 full year estimates Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% Packaging 31% Consumer 28% Healthcare 8% Industrial 13% Building & Construction 5% Telecommunications 3% Energy 2% Defense 1% Asia (20% of sales) Transportation 9% 2022 PROFORMA AVIENT REGIONAL SALES BY END MARKET Packaging 29% Consumer 13% Healthcare 5% Industrial 17% Building & Construction 11% Energy 5% Defense 7% EMEA (35% of sales) Transportation 10% Packaging 14% Consumer 23% Healthcare 11% Industrial 15% Building & Construction 12% Energy 5% Defense 7% US & Canada (40% of sales) Transportation 7% Packaging 49% Consumer 22% Healthcare 8% Industrial 9% Building & Construction 6% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3%Telecommunications 6% Figures represent 2022 full year estimates32

For Unit 1.8 1.4 1 .6 .2 2007 2010 2013 20 $ M IL L IO N S U .S . D O L L A R S *Pro Forma for sale of DSS 2009 2010 2011 2012 2013 2014 2015 2016* 2017* 2018 2018 2019 $2.21 $0.13 $0.68 $0.82 $1.00 $1.31 $1.80 $2.43 $2.06 $1.96 Pro Forma for sale of PP&S $1.69 $1.51 12 31 2018 3 31 2019 6 30 2019 9 30 2019 12 31 2019 +32% 2019 POL Stock Price Performance $ U .S . For the year, our stock price increased 32%, outpacing the S&P 500 and S&P Mid Cap Index.

Microsoft PowerPoint - AVNT Nov Investor Meetings Update AVIENT CORPORATION I N V E S TO R M E E T I N G S (NYSE: AVNT) N OV E M B E R 2 0 2 1 DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L A S H E M N C E S C L Source: Peer data per Bloomberg market data as of November 8, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. With the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 33 Avient reflects 2021 estimated EBITDA of $580M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 11.4 20.2 16.7 16.5 14.7 12.0 10.8 40.7 29.9 26.2 13.2 12.4 11.0 10.9 9.1 9.0 7.5 6.5 A vi en t K W R P P G A V Y R P M F U L G C P A L B H X L E C L A S H F M C B N R S C L U N V R E M N C E H U N SUMMARY: WHY INVEST IN AVIENT?

Microsoft PowerPoint - Avient IR Presentation - May 2021 AVIENT CORPORATION M AY 2 0 2 1 I N V E S T O R M E E T I N G S (NYSE: AVNT) DISCLAIMER 2 Forward-Looking Statements In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. D is t. ) K W R R P M P P G A V Y F U L G C P IF F H X L F M C F O E H U N E C L K R A E M N A S H C E S C L G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of April 27, 2021 Avient reflects 2021 estimated revenue of $4,300M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 28 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi en t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?